PA
HON icon

PharVision Advisers’s Honeywell HON Stock Holding History

PharVision Advisers’s Portfolio HON Stock Details HON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,177
Closed -$230K – 347
2025
Q4 		$230K Sell
1,177
-1,472
-56% -$288K 0.12% 447
2025
Q3 		$526K Buy
2,649
+1,282
+94% +$268K 0.3% 20
2025
Q2 		$300K Buy
+1,367
New +$277K 0.43% 82

Other funds holding HON

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

PharVision Advisers's HON Position: Q1 2026 in Review

PharVision Advisers sold out of Honeywell (HON) in Q1 2026, closing a stake of 1,177 shares — an estimated $230K sold.

PharVision Advisers first reported a position in HON in Q2 2025 and held it in 3 quarters. The position peaked at $526K in Q3 2025. 2,793 funds tracked by Wall St. Rank hold HON as of Q1 2026.

  • PharVision Advisers reported no remaining Honeywell position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 1,177 Honeywell shares in Q1 2026, an estimated $230K.
  • PharVision Advisers first reported a position in Honeywell in Q2 2025 and held it in 3 quarters.
  • PharVision Advisers's Honeywell position peaked at $526K in Q3 2025.
  • 2,793 funds tracked by Wall St. Rank held Honeywell as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.